BCL2 and acute lymphoblastic leukemia: Moreover, in vitro pre-sensitization of B-ALL cells with the Bcl-2 inhibitor venetoclax resulted in an enhanced CAR T cell mediated cytotoxicity by upregulating the CD19 expression and pro-apoptotic proteins [87].